Searchable abstracts of presentations at key conferences in endocrinology

ea0029p111 | Adrenal cortex | ICEECE2012

A case of subclinical Cushing’s syndrome who developed pseudo-aldosteronism caused by green juice

Ohashi K. , Hayashi T. , Saito T. , Yamazaki H. , Tojo K. , Utsunomiya K.

Seventy six-year-old man was referred to our hospital for examination of hypertension and hypokalemia. His blood pressure was uncontrolled although he was taking amlodipine besilate, spironolacton and candesartan. In addition, he suffered from atrial fibrillation and chronic heart failure. His serum potassium was low (2.8 mmol/l) and bilateral adrenal glands were found swelling. Hence, we investigated him thoroughly on the suspicion for primary aldosteronism.<p class="abst...

ea0029p989 | Growth hormone IGF axis - basic | ICEECE2012

Ghrelin suppresses angiotensin II-induced tissue damages by reducing oxidative stress

Fujimura K. , Wakino S. , Minakuchi H. , Tokuyama H. , Hayashi K. , Itoh H.

Objectives: Angiotensin II (AngII) induces renal premature senescence by multiple mechanisms including by increasing oxidative stress. Recent study revealed that growth hormone secretagogue ghrelin exerts anti-senescence effects. In this study, we examined whether ghrelin inhibits AngII-induced renal senescence and damages.Methods: Renal senescence was induced by infusion of Ang II in C57BL/6 mice with osmotic mini-pump. Ghrelin was administered by the d...

ea0029p453 | Clinical case reports - Thyroid/Others | ICEECE2012

Marked improvement of gastrointestinal pseudo-obstruction after debulking surgery of malignant pheochromocytoma by Intravenous administration of α-blocker phentolamine

Yamaguchi S. , Shibata H. , Miyashita K. , Kurihara I. , Oguchi H. , Futatsuki K. , Murai-Takeda A. , Mitsuishi Y. , Motosugi Y. , Jo R. , Hayashi K. , Itoh H.

We present a case of severe malignant pheochromocytoma complicated with intestinal pseudo-obstruction, which was refractory to conventional therapies but reacted to intravenous administration of an α-blocker, phentolamine.Malignant pheochromocytoma typically metastasizes to bones, liver, lungs, and lymph nodes, and average 5-year survival rate in the patient with metastases is approximately 50%. Treatment options for malignant pheochromocytoma inclu...